Status: Not yet recruiting
A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia
This study intends to evaluate the efficacy and safety of eravacycline-based combination therapy in real words for Chinese patients with CRAB pneumonia, providing data reference for clinical treatment of CRAB pneumonia.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Peking University Third HospitalUpdated: Nov 1, 2024Locations: 2Duration: 28 Days
Eligibility criteria
Aged 18 years or older. [+3]
The investigator believes that there are any medical history, current condition,... [+1]